Delivery Order SPE2DB22D2206-SPE2DB24FEH34
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FGU13 to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $3,980.34 Firm Fixed Price contract is for the supply of Carafate 1 GM/10 ML Suspension 420 ML, with a completion date of April 22, 2024. This order is part of Amerisourcebergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under this...
- This contract award, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for the treatment of gastrointestinal conditions. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of October 31, 2023. The contract does not have a...
- The federal contract award is for the delivery of Carafate 1 GM/10 ML Suspension 420ML to the Defense Logistics Agency (DLA). The contract, valued at $2,938.02, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,279.01 firm fixed price delivery order is for the supply of Carafate 1 GM/10 ML suspension, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on an indefinite...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract valued at $2,356.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is issued under a...
- This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Carafate 1 GM/10 ML Suspension in 420 ML bottles. The contract has a ceiling value of $3,983.93 and a completion date of July 19, 2023. The contract is a firm fixed-price type without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a for-profit...
- This federal contract award is for the delivery of Carafate 1 GM tablets to the Defense Logistics Agency (DLA). The contract, valued at $6,503.71, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,895.76 firm fixed-price delivery order is for the supply of CARAFATE 1 GM/10 ML SUSP 420ML, a pharmaceutical product. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp, the prime contractor, has a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,407.63, is for the delivery of CARAFATE 1 GM TABLET 100S, a medical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $14,549.79 delivery order is for the supply of Carafate 1 GM Tablets, a pharmaceutical product used for the treatment of ulcers. The contract has an ultimate completion date of December 11, 2023 and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FEH34Delivery Order
This federal contract award SPE2DB22D2206|SPE2DB24FEH34, valued at $1,895.76, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carafate 1 GM/10 ML Suspension, a pharmaceutical product used for various medical purposes. The award has an ultimate completion date of November 28, 2023. This contract is a delivery order with a firm fixed price, and it is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/27/23 |